Nonalcoholic steatohepatitis (NASH) may account for many cases of cryptogenic cirrhosis. If so, then steatosis might recur after liver transplantation. Two thousand fifty-two patients underwent primary liver transplantation for chronic liver disease between 1986 and 2004. Serial liver biopsy samples
HFE mutations in nonalcoholic fatty liver disease
β Scribed by Luca Valenti; Paola Dongiovanni; Anna Ludovica Fracanzani; Silvia Fargion
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 61 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Li et al. have analyzed golgi phosphoprotein 2 (GOLPH2) serum levels in a cohort of patients with liver cirrhosis, healthy controls, and patients with hepatocellular carcinoma (HCC). They found elevated serum levels of GOLPH2 (sGOLPH2) in early HCC cases. From their findings, the authors conclude th
Nonalcoholic fatty liver disease affects a substantial proportion of the general population worldwide. This high prevalence of nonalcoholic fatty liver disease has important consequences in the donor selection process for liver transplantation, and in the posttransplant period given the high recurre
We read with interest the articles on hepatic venous pressure gradient (HVPG) measurements. [1][2][3] We fully agree on the need to standardize HVPG measurements to get reliable, reproducible, and useful data. 1 We also agree that before recommending such measurements in clinical practice, it is nec
The mechanism(s) determining the progression from fatty liver to steatohepatitis is currently unknown. Our goal was to define the relative impact of iron overload, genetic mutations of HFE, and insulin resistance on the severity of liver fibrosis in a population of subjects with nonalcoholic fatty l